Search

You searched for "microscopic"

673 results found

Managing CRS in pregnancy

1 November 2016 |
An International team of experts from both sides of the Atlantic set out to perform a systematic review of the management of chronic rhinosinusitis in pregnancy. Despite a thorough search no scientific evidence was found that could form the basis...

Standardising outcome measures in chronic rhinosinusitis

1 September 2018 |
This international paper, involving the foremost rhinology departments worldwide aims to provide a standardised, agreed core outcome set for chronic rhinosinusitis, which has been designed to facilitate future meta analyses of published work in systematic reviews. Stakeholders included patients, ENT...
ALLERGY cover

CRSwNP, another monoclonal antibody

1 July 2019 | | ENTA - Rhinology / Sinus | biomarkers, dupilumab, nasal polyposis, nasal secretions, type 2 inflammation
Interleukins 4, 5 and 13 were shown to be important factors in type 2 inflammation, which characterises chronic rhinosinusitis with nasal polyposis (CRSwNP). In CRSwNP non-responders and those who recur short after-surgery monoclonal antibodies might be an answer. Examples include...
Journal of Voice journal cover image

Early injection laryngoplasty for iatrogenic vocal fold movement impairment – a safe and effective treatment

30 April 2020 | | ENTA - Laryngology / Swallowing / Voice | Aspiration, Deglutition and deglutition disorders, Dysphagia, Injection, Laryngoplasty, Recurrent laryngeal nerve, Vocal fold movement impairment
This Ed’s Choice examines the role of early injection laryngoplasty on swallowing dysfunction and is one of a few studies available in the literature. Research on early injection laryngoplasty has been predominately focused on voice and reducing the risk of...

Outcomes of office-based biopsies for laryngopharyngeal carcinoma – faster diagnoses and equivalent oncological outcomes as compared to biopsies under general anaesthesia

7 January 2025 | | ENTA - Head & Neck
Patients in the UK with head and neck cancers are the most likely to face long waits to treatment in comparison to other cancer sites, with only just over half commencing treatment within 62 days of being referred on a...

Patients with severe uncontrolled CRSwNP respond to biologics in the real world

2 May 2025 | | ENTA - Rhinology / Sinus
Clinical trials have demonstrated that biologics are effective in treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This multicentre (15 tertiary care centres in France) observational prospective cohort study aims to examine the effectiveness of biologics in treating CRSwNP...

The impact of simulation on ENT training

3 July 2023 | | ENTA - General
Surgical training is constantly developing to improve ENT surgeons’ technical and non-technical skills. In this article, Joshua Whittaker, an ENT Registrar and ENT Simulation Fellow at University Hospitals Birmingham, describes the rise of simulation training. Simulation is the recreation of...

Advanced in-office awake rhinology

2 May 2025 | | ENTA - Rhinology / Sinus
In-office awake rhinology transforms sinonasal care, offering safe, cost-effective, minimally invasive procedures with rapid recovery and high patient satisfaction. In recent years, the landscape of otolaryngological surgery has undergone a remarkable transformation with the advent of in-office awake surgical procedures....

Nasal septal perforation repair

1 March 2018 | | ENTA - Rhinology / Sinus
Nasal septal perforation repair has traditionally been a great challenge. Many surgical techniques are described, however the success rate of closure has often been poor. Experience from the use of pedicled vascularised mucosal flaps in skull base surgery has been...

Atmos Scope: New standards in ENT endoscopy and swallowing diagnostics in HD quality

4 April 2022 | Research & Development
In April, Atmos MedizinTechnik GmbH & Co. KG will launch the next generation of endoscopes for ENT and swallowing diagnostics— the Atmos Scope.

The central ENT decontamination model: a help or a hindrance?

1 September 2022 | Company Profiles, Research & Development
According to NHS England, over 400,000 patients were waiting for ENT treatment in the UK in January 2022. This figure forms part of the overall 33.5% increase in the number of patients waiting for Referral to Treatment (RTT) compared to February 2020[1].

KARL STORZ Strengthens its ENT Portfolio with the Acquisition of AventaMed in Ireland

8 February 2023 | Contracts & Distributors
The family-owned medical technology company KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company.